Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients

Merchante Nicolas; Rodriguez-Arrondo Francisco; Revollo Boris; Merino Esperanza; Ibarra Sofia; Galindo Maria J.; Montero Marta; Garcia-Deltoro Miguel; Rivero-Juarez Antonio; Tellez Francisco; Delgado-Fernandez Marcial; Rios-Villegas Maria J.; Garcia Maria A.; Vera-Mendez Francisco J.; Ojeda-Burgos Guillermo; Lopez-Ruz Miguel A.; Metola Luis; Omar Mohamed; Remedios Aleman-Valls Maria; Aguirrebengoa Koldo; Portu Joseba; Raffo Miguel; Macias Juan; Pineda Juan A.

首页> 外文期刊>AIDS >Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients

【24h】

Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients

机译：肝细胞癌持续的病毒学反应与艾滋病毒/丙型肝炎病毒 - 纺织患者的无干扰素方案

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To assess the possible association between the use of direct antiviral agents (DAA) and the risk of hepatocellular carcinoma (HCC) in HIV/hepatitis C virus (HCV)-coinfected patients.

机译：目的：评估使用直接抗病毒剂（DAA）和肝细胞癌（HCC）中的肝细胞癌（HCV） - COINFET患者的风险之间的可能关联。

著录项

来源
《AIDS》 |2018年第11期|共8页
作者
Merchante Nicolas; Rodriguez-Arrondo Francisco; Revollo Boris; Merino Esperanza; Ibarra Sofia; Galindo Maria J.; Montero Marta; Garcia-Deltoro Miguel; Rivero-Juarez Antonio; Tellez Francisco; Delgado-Fernandez Marcial; Rios-Villegas Maria J.; Garcia Maria A.; Vera-Mendez Francisco J.; Ojeda-Burgos Guillermo; Lopez-Ruz Miguel A.; Metola Luis; Omar Mohamed; Remedios Aleman-Valls Maria; Aguirrebengoa Koldo; Portu Joseba; Raffo Miguel; Macias Juan; Pineda Juan A.;
展开▼
作者单位

Hosp Univ Valme Unidad Clin Enfermedades Infecciosas &

Microbiol Ave Bellavista S-N Seville;

Hosp Univ Donostia San Sebastian Spain;

Hosp German Trias i Pujol Badalona Spain;

Hosp Gen Univ Alicante Alicante Spain;

Hosp Basurto Bilbao Spain;

Hosp Clin Univ Valencia Valencia Spain;

Hosp Univ &

Politecn La Fe Valencia Spain;

Hosp Gen Valencia Valencia Spain;

Hosp Univ Reina Sofia Inst Maiomonides Invest Biomed Cordoba IMIBIC Cordoba Spain;

Hosp Univ Puerto Real Hosp La Linea Inst Invest &

Innovac Ciencias Biomed Prov Cadiz Cadiz Spain;

Hosp Reg Univ Malaga Malaga Spain;

Hosp Univ Virgen Macarena Seville Spain;

Hosp Galdakao Galdakao Spain;

Hosp Gen Univ Santa Lucia Cartagena Spain;

Hosp Virgen de la Victoria Malaga Spain;

Hosp Univ Virgen de las Nieves Granada Spain;

Hosp San Pedro Logrono Spain;

Complejo Hosp Jaen Jaen Spain;

Hosp Univ Canarias Tenerife Spain;

Hosp Cruces Bilbao Spain;

Hosp Txagorritxu Vitoria Spain;

Complejo Hosp Huelva Huelva Spain;

Hosp Univ Valme Unidad Clin Enfermedades Infecciosas &

Microbiol Ave Bellavista S-N Seville;

Hosp Univ Valme Unidad Clin Enfermedades Infecciosas &

Microbiol Ave Bellavista S-N Seville;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词
hepatitis C virus; hepatocellular carcinoma; HIV; liver cirrhosis; sustained virological response;

机译：丙型肝炎病毒;肝细胞癌;艾滋病毒;肝硬化;持续的病毒学反应;

相似文献

外文文献
中文文献
专利

1. Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients [J] . Merchante Nicolas, Rodriguez-Arrondo Francisco, Revollo Boris, AIDS . 2018,第11期

机译：肝细胞癌持续的病毒学反应与艾滋病毒/丙型肝炎病毒 - 纺织患者的无干扰素方案
2. HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma [J] . MerchanteN., MerinoE., Rodríguez-ArrondoF., AIDS . 2014,第1期

机译：艾滋病毒/丙型肝炎病毒 - 携带持续病毒学反应的患者仍然有患肝细胞癌的风险
3. Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/hepatitis C virus-coinfected patients with advanced liver disease [J] . Mandorfer Mattias, Schwabl Philipp, Steiner Sebastian, AIDS . 2016,第7期

机译：索非布韦/达卡他韦的无干扰素治疗可在100％感染HIV /丙型肝炎病毒的晚期肝病患者中实现持续的病毒学应答
4. Patients with HCV/HIV Co-infection Achieving a Sustained Virological Response Following HCV Treatment with Peginterferon alfa-2a (PEGASYS) plus Ribavirin (COPEGUS) have Improved Health Related Quality of Life [C] . D.T. Dieterich, M. Rodriguez Torres, J.K. Rockstroh International AIDS Conference . 2004

机译：HCV / HIV的患者在用Peginterferon Alfa-2a（Pegasys）加上利巴韦林（Copegegs）后HCV治疗后实现持续的病毒学反应，具有改善的健康相关的生活质量
5. Baseline Toronto HCC Risk Index (THRI) and Albumin Predict Low Risk of Hepatocellular Carcinoma (HCC) after Sustained Virological Response (SVR) in HCV Infection [D] . Lau, Jason. 2019

机译：基线多伦多HCC风险指数（THRI）和白蛋白预测HCV感染持续病毒响应（SVR）后肝细胞癌（HCC）的低风险
6. The Incidence of Hepatocellular Carcinoma Is not Increased in Individuals with Chronic Hepatitis C After Treatment with Interferon-free Regimens: an ERCHIVES Study [O] . Darrick K Li, Yanjie Ren, Obaid Saikh, 2017

机译：ERCHIVES研究显示无干扰素治疗后慢性丙型肝炎患者肝细胞癌的发生率未增加
7. Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis [O] . Nicolás Merchante, Antonio Rivero-Juárez, Francisco Téllez, 2018

机译：对直接作用抗病毒方案的持续病毒学反应降低了肝硬化患者肝细胞癌肝细胞癌的风险

Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients

摘要

著录项

相似文献

相关主题

期刊订阅